MDoutlook is a leading disease intelligence company.
We build the success of your organization through better decision-making.


Specializing in oncology, rare and ultra-rare diseases, we answer your business questions using custom market research instruments, our proprietary disease panels, our client side experience and our depth of clinical understanding.


Driven by staff medical experts, our team engages with ThoughtLeaders and the right clinicians to deliver real-world, actionable insights.


Our solutions
MDoutlook provides custom and syndicated market research, ThoughtLeader identification and network mapping, and guaranteed physician engagement.


Click on the above icons to explore how our clients derive value.

What's New at MDoutlook

Biomarkers are valued but 1 in 3 oncologists want improvement

16 Apr 2019

Biomarkers are embraced by oncologists as an important tool in their arsenal to treat cancer. They enable a more personalized approach to treatment by identifying…


Oncologists have no clear leader in pharma engagement solutions

01 Apr 2019

Oncologists have no clear leader when asked about the supportive services and tools provided to them by pharmaceutical companies. Our 2019 Leadership study in ImmunoOncology…


Value of medicines is number one concern for oncologists

21 Mar 2019

Financial impact and affordability of medicines is the number one concern for oncologists in our 2019 Leadership research in ImmunoOncology. Oncologists were asked to choose…


What's Trending in Oncology (updated hourly)